Acuvail 0.45 % (Ketorolac Tromethamine SOLUTION) 0.45 %

ACUVAIL 0.45% is an ophthalmic solution containing ketorolac tromethamine, used for eye-related conditions. This nonsteroidal anti-inflammatory drug (NSAID) helps reduce inflammation and pain in the eyes.

Strength

0.45 %

Pack Size

0.4ML VIAL

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ACUVAIL 0.45% is primarily used for the treatment of inflammation and pain following eye surgery. It is an ophthalmic solution designed to be applied directly to the eye. Ketorolac tromethamine, the active ingredient, works by reducing the production of prostaglandins, which are chemicals that cause inflammation and pain. This makes it useful for managing post-surgical discomfort and swelling in the eyes.

Side Effects

When used as directed, ACUVAIL 0.45% may help alleviate eye pain and reduce inflammation. Some users might experience temporary blurred vision or mild irritation after application. These effects are generally short-lived and should subside quickly.

Precautions & Warnings

ACUVAIL 0.45% should be used strictly as directed by a healthcare professional. Avoid touching the tip of the dropper to prevent contamination. If you experience persistent irritation or worsening symptoms, discontinue use and consult a healthcare provider. Keep out of reach of children and store at room temperature unless otherwise specified.

Avoid Interactions

ACUVAIL 0.45% may interact with other medications, including other NSAIDs and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this ophthalmic solution.

Frequently Asked Questions

ACUVAIL 0.45% is used to reduce inflammation and pain following eye surgery.

ACUVAIL 0.45% is an ophthalmic solution that should be applied directly to the eye as directed by a healthcare professional.

Common side effects may include temporary blurred vision or mild eye irritation.

It is important to consult a healthcare provider before using ACUVAIL 0.45% with other medications to avoid potential interactions.

ACUVAIL 0.45% should be stored at room temperature unless otherwise specified by the manufacturer.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.